Oncology Pharma Appoints Dr. Vijay Mahant as the Chief Scientific Officer and Chief Operating Officer

NEXT STORY
Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
PREV STORY
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics Reports Fiscal Year 2017 Financial Results

MINNEAPOLIS, April 02, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News

Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

Depyrogenated Sterile Empty Vials Market to hit $8 billion by 2025: Global Market Insights, Inc.

author_avatar
NASDAQ Market News